Posts filtered by tags: Biotech[x]


 

The 9 biotechs that stand to win after the FDA took a new approach to approving Biogen's Alzheimer's drug

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We found the 9 biotechs that stand to benefit after the FDA approved a new Alzheimer's drug;A top investor at General Atlantic explained why he's betting on telemedicine;Clover Health got the WallStreetBets treatment, closing up more than 80% on Tuesday.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get t...
Tags: Mexico, Trends, Bloomberg, Canada, Atlantic, Healthcare, Alzheimer's, Fda, Biotech, General Atlantic, Gamestop, Clover Health, Chamath Palihapitiya, Robb, US State Department, Biogen


We just got the first new Alzheimer's drug in nearly 2 decades

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:On Monday, the FDA approved the first new Alzheimer's drug in nearly two decades;Primary care company One Medical wants to tap into senior care by acquiring competitor Iora Health;We looked into an old Medicare policy that could get in the way of patients accessing the newly approved Alzheimer's drug.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected]
Tags: Washington Post, US, Trends, Getty Images, Alzheimer's Disease, Healthcare, Medicare, Fda, Biotech, Biden, Fairfax Media, William Burke, Biogen, Newsletters, Primary Care, One Medical


Global stocks hover below record highs ahead of US inflation data, while oil falls for a 2nd day as demand optimism fades

Spencer Platt/Getty Images Global stocks traded just under record highs as investors awaited inflation data later this week. Bitcoin fell to two-week lows around $33,000, while other major tokens fell more than 9%. Oil retreated from 2-year highs, but slowing cases of COVID-19 might limit losses. Sign up here for our daily newsletter, 10 Things Before the Opening Bell. Global stocks mostly edged lower on Tuesday as investors remained focused on inflation data, with the US consumer price i...
Tags: Europe, UK, London, India, US, Trends, Joe Biden, Frankfurt, Bitcoin, Shanghai, Ubs, Deutsche Bank, Cornwall, Tokyo, Brent, Fda


The FDA just approved the first new Alzheimer's drug in 18 years

Dr. William Burke going over a PET brain scan at Banner Alzheimer's Institute in Phoenix. Biogen's drug was tested against carriers of the APOE gene, which is linked to Alzheimer's, and non-carriers. Matt York/Associated Press The FDA on Monday approved the first new Alzheimer's disease treatment in nearly two decades. Biogen had initially deemed the drug a failure and shut down two late-stage trials. Experts were divided on the drug. One analyst had estimated a 15% chance ...
Tags: Science, News, Trends, Alzheimer's Disease, Healthcare, Food And Drug Administration, Fda, Biotech, Agency, Citi, Alzheimer, William Burke, RBC Capital Markets, Biogen, Eli Lilly, Namenda


Molecule.one grows its drug synthesis AI platform with a $4.6M seed round

Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. Molecule.one went on stage at Disrupt SF 2019’s Startup Battlefield, where they explained the difficulty faced by the drug discovery industry, basically that they come up with lots of theoretical treatments but can...
Tags: Fundings & Exits, Startups, TC, Funding, Tech, Artificial Intelligence, Biotech, Battlefield, Bayer, Western Europe, Mila, Startup Battlefield, Recent Funding, Molecule.one, CSO Stanisław Jastrzębski, Piotr Byrski


3 lingering questions about COVID-19 vaccines will shape the pandemic's trajectory into 2022 and beyond

A medical assistant administers a COVID-19 vaccine dose to a woman at a clinic in Los Angeles on March 25, 2021. Mario Tama/Getty Images Coronavirus vaccines have been a stunning success story of the pandemic. But there are still a few key unanswered questions about the COVID-19 vaccines we have. Some of the biggest: How long does vaccine protection last, and how good will it be against new variants? See more stories on Insider's business page. Hot vax summer is here.More than half o...
Tags: Science, News, Cdc, India, New York City, US, Toronto, Los Angeles, Trends, South Africa, Healthcare, Poland, World Health Organization, Fda, University of Pennsylvania, Pfizer


What's shaking up the future of the retail pharmacy

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:Blake Dodge's scoop on Amazon's bricks-and-mortar pharmacy ambitions shook up healthcare stocks;Dealmaking is heating up heading into the summer - for biotech and digital health;How Wall Street is betting on primary care companies.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it...First, I hop...
Tags: Amazon, Trends, Healthcare, M&a, Biotech, Digital Health, Bessemer, Pharmacy, Kelly, Blake, Miami Florida, Allison, Newsletters, Akili, Moderna, Could Amazon


Moderna says its coronavirus vaccine is effective in teens, and the biotech plans to apply in early June for an expanded OK

A coronavirus vaccine trial volunteer receives a shot. Glenn Asakawa/University of Colorado Moderna's coronavirus vaccine likely works in teens, according to study results that the biotech plans to submit to regulators next month. The vaccine could become the second OK'd for people as young as 12. Teens in Moderna's study had similar immune responses as adults who received the shot. See more stories on Insider's business page. Moderna's coronavirus vaccine appears to be...
Tags: Health, Science, News, Massachusetts, Trends, Healthcare, Pfizer, Biotech, US Food and Drug Administration, Pharmaceutical, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine, Dispensed


22 biotech companies that will likely get bought as M&A heats up this summer

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:22 biotech companies that will likely get bought;Why the technology used to develop Pfizer's and Moderna's shots could help us treat more diseases;The next big public health threat is drug-resistant fungi.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... A research scientist working at Arro...
Tags: Trends, Healthcare, Pfizer, Resistance, Biotech, Yankees, Jefferies, Candida, Newsletters, Vertex, Fungus, Moderna, mRNA, COVID, Lydia Ramsey Pflanzer, Dispensed


‘It’s almost like placing an IV’: Brain monitoring electrode receives FDA 510(k) clearance

An FDA pathway that’s greased the gears for COVID-19 vaccines and drugs has paved the way for something else: a new take on electroencephalography (EEG), the established brain-monitoring technique in which metallic electrodes are placed on the scalp to measure the brain’s electrical activity.  On May 17, DC-based startup iCE Neurosystems announced a version of FDA approval for a subcutaneous electrode called iCE-SG, designed to monitor the brain’s electrical activity from beneath the sk...
Tags: Health, TC, Neuroscience, Tech, Fda, Biotech, Medical Device, Columbia, Eeg, Electroencephalography, New England Journal of Medicine, EUA, Columbia University Medical Center, Waziri, Software Platform, Alan Waziri


INSIDE BIOTECH: See the drug companies that are growing the fastest and pay workers the most

Hinterhaus Productions/Getty Images Insider compiled data on the fastest-growing biotechs and pharmas, and what they're paying employees and executives. Hiring and retaining workers has been a challenge in the drug industry, leading to competitive pay packages. One company paid its median employee $701,000, while dozens of CEOs earned more than $18 million. See more stories on Insider's business page. As the drug industry has grown, companies are competing to hire and retain the...
Tags: Trends, Pay, Compensation, Healthcare, Biotech, Pharma, Hiring, Novavax, Company Growth, Moderna, Stanley Erck, Getty Image, Precigen, COVID, Dispensed, Subscriber Collection


These are the fastest-growing biotech companies

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We found the 29 fastest-growing biotechs;Sanofi and GSK get promising results for their COVID-19 shot;Amazon is launching a diagnostics brand, Insider has learned.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... The biotech Moderna is working to develop personalized cancer treatments that are cust...
Tags: Amazon, US, Trends, Paris, Healthcare, Medicare, GlaxoSmithKline, Vaccine, Biotech, Clover Health, Sanofi, GSK, Newsletters, Diagnostics, Moderna, Reuters Sanofi


With $21M in funding, Code Ocean aims to help researchers replicate data-heavy science

Every branch of science is increasingly reliant on big data sets and analysis, which means a growing confusion of formats and platforms — more than inconvenient, this can hinder the process of peer review and replication of research. Code Ocean hopes to make it easier for scientists to collaborate by making a flexible, shareable format and platform for any and all datasets and methods, and it has raised a total of $21M to build it out. Certainly there’s an air of “Too many options? Try this one!...
Tags: Fundings & Exits, Startups, Cloud, Science, Cloud Computing, Funding, Tech, Ocean, SaaS, Biotech, Battery Ventures, Recent Funding, Code Ocean, Digitalis Ventures EBSCO, Vaal Partners


How much you can make working at top biotech companies

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We analyzed compensation at 189 biotech companies, finding the highest-paid CEOs and the highest median pay;Providing care at home is a booming industry - and major health systems are working through how to provide more hospital-level care at home;Rivalries are bubbling up as giants like Amazon and Walmart bet more on healthcare.If you're new to this newsletter, sign up here. Tips, comments? ...
Tags: Apple, Amazon, Cdc, Kaiser Permanente, Wall Street, Trends, Walmart, Humira, Healthcare, Pfizer, Biotech, Morgan Stanley, Kelly, Andrew, Blake, Humana


We found out how much typical employees at 23 biotechs make

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, back at the helm of this daily newsletter. Today in healthcare news:We found out how much typical employees at 23 biotechs make;Two major health systems are making a big bet on hospital-level care at home;A CDC panel signs off on Pfizer's shot for 12- to 15-year-olds.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... pictu...
Tags: Amazon, Florida, Cdc, Kaiser Permanente, US, Newsletter, Trends, Pay, Hospitals, New Jersey, Healthcare, Pfizer, Biotech, Mayo Clinic, PillPack, Reata Pharmaceuticals


Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M

While much of the world eagerly watches to see if the vaccination rollout helps curb and eventually stamp out Covid-19, one of the companies that has been helping to manage the spread of the virus is announcing a big round of funding on the heels for strong demand for its technology. Huma, which combines data from biomarkers with predictive algorithms both to help monitor patients, and uses the same technology to help researchers and pharmaceutical companies run clinical trials, has closed an eq...
Tags: Health, Google, Asia, Europe, UK, London, India, Softbank, Funding, US, Samsung, Tech, Artificial Intelligence, NHS, Sony, Pfizer


Healthcare is Amazon and Walmart's latest battleground

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, back at the helm of this daily newsletter. Today in healthcare news:How Amazon and Walmart stack up in their latest battleground, healthcare;We rounded up the 17 highest-paid drug industry CEOs;Morgan Stanley analysts lay out how Amazon could change how benefits are designed.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it...But firs...
Tags: Amazon, US, Trends, Walmart, Healthcare, Astrazeneca, Fda, Pfizer, Biotech, Biden, Pharma, Morgan Stanley, Trump, US Food and Drug Administration, Reuters Morgan Stanley, Newsletters


We just got our first evidence that Moderna's coronavirus booster shot works to fight variants

Lab tech Sendy Puerto processes blood samples from Moderna's coronavirus vaccine clinical trials study participants September 2, 2020 in Miami, Florida. Taimy Alvarez/AP Moderna said Tuesday a third dose greatly boosted antibody levels in volunteers in a new study. This updated vaccine, tailored against the B.1.351 variant, worked best, the company said. These are the first clinical results from any vaccine developer testing an updated version of a COVID-19 shot. See more stories on In...
Tags: Health, Science, Trends, South Africa, Healthcare, Brazil, Pfizer, Biotech, Moderna, Andrew Dunn, Stéphane Bancel, Coronavirus, Coronavirus Vaccine, Sendy Puerto, AP Moderna, Miami Florida Taimy Alvarez


Welcome to the era of 'mega biotechs'

Hello,Welcome to Insider Healthcare. I'm Shelby Livingston, and I cover how healthcare is paid for and delivered in the US for the Insider healthcare team. Today in healthcare news:The era of "mega biotechs" has arrived, and these startups are drawing high valuations that they could fail to live up to;Pfizer outlined a busy 2021 for its coronavirus shot, which the company projects will bring in $26 billion in revenue this year;Experts believe the US is getting closer to achieving herd immuni...
Tags: US, Trends, Pennsylvania, Healthcare, Denmark, Pfizer, Biotech, Johnson Johnson, Los Angeles California, Newsletters, Proskauer, STAT, Crystal Cox, Cal State LA, Coronavirus, COVID


Moderna's mRNA technology could help in the decades-long search for an HIV vaccine

Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021. While "excited" by the prospect, HIV researchers caution there's a long road ahead for mRNA vaccines....
Tags: Science, Massachusetts, New York City, Trends, Thailand, South Africa, Healthcare, University of Pennsylvania, Pfizer, Lincoln Center, Biotech, National Bureau of Economic Research, Nih, Frank, Emory University, Johnson Johnson


C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, will the doctors catch it at an early enough stage? C2i Genomics has developed software that’s 100x more sensitive in detecting residual disease, and investors are pouncing on the potential. Today, C2i announced a $100 million Series B led by Casdin Capital.  “The biggest question in cancer treatme...
Tags: Health, Startups, TC, Cloud, New York, Singapore, Cancer, Funding, Tech, Artificial Intelligence, SaaS, Surgery, Fda, Cancer Treatment, Biotech, Radiation


Highlights from Berkeley SkyDeck’s virtual demo day

With 17 startups participating, Berkeley SkyDeck’s Demo Day isn’t the largest cohort we’ve seen by any stretch. The collection of companies is, however, defined by a wide range of focuses, from pioneering diabetes treatments to retrofitting autonomous trucking, curated by the SkyDeck’s small team and a number of advisors. Founded in 2012, the accelerator is focused on developing early-stage companies tied to the University of California system. Applicants must be affiliated with either one of th...
Tags: Startups, Hardware, Funding, Tech, Automotive, Venture Capital, Biotech, Robotics, Berkeley, University Of California, Los Alamos, Uc-berkeley, Skydeck, Kiwi, Ontario, UCSF


Pfizer's COVID-19 shot remains highly protective against the coronavirus, longer-term data shows

The arrival of coronavirus vaccines means people have started hawking so-called "vaccines" on the Dark Web. CHRIS JACKSON/POOL/AFP via Getty Images Pfizer released new data from a key study, showing lasting benefits for its COVID-19 vaccine. The two-dose vaccine was 91% effective at preventing symptomatic cases of COVID-19. Data from study volunteers in South Africa suggests the shot also fights concerning variants. See more stories on Insider's business page. Updated results from Pfiz...
Tags: Health, Science, News, US, Trends, South Africa, Healthcare, Astrazeneca, Pfizer, Oxford University, Biotech, Pharmaceutical, Chris Jackson, Reuters Pfizer, Centers for Disease Control and Prevention The, Andrew Dunn


The US just launched the first study testing a version of Moderna's coronavirus vaccine tailored to fight a concerning variant

Richard Biggs, 20, an evolutionary biology major at the University of Colorado Boulder gets his first dose of the Moderna vaccine from Dr. Laird Wolfe. Glenn Asakawa/University of Colorado The first clinical trial testing a variant-specific COVID-19 shot launched Wednesday. The NIH-sponsored study will test an updated version of Moderna's coronavirus vaccine. The shot is designed to fight the B.1.351 strain first identified in South Africa. See more stories on Insider's business p...
Tags: Health, Science, News, Massachusetts, US, Trends, South Africa, Healthcare, Biotech, Seattle, Nih, Jefferies, University of Colorado Boulder, US National Institutes of Health NIH, Richard Biggs, Moderna


Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation

Vibrant, a medical technology company that’s developed a disposable vibrating pill to treat chronic constipation, today announced its Series E for $7.5 million. The company is based in Tel Aviv and is lead by Lior Ben-Tsur, a startup veteran. Since its founding in 2007, the company has raised a total of $25 million. This round is being led by Unorthodox Ventures with participation by Sequoia. Vibrant, which is going through its third and final round of Food and Drug Administration (FDA) testing,...
Tags: Health, TC, Tel Aviv, Insurance, Tech, Ceo, United States, Food And Drug Administration, Biotech, Chemicals, Health Tech, Medical Technology, Medical Tech, Food and Drug Administration FDA, American Gastroenterological Association, Capsule


Y Combinator’s biotech startups incubate a new generation of therapies and tools

Medical and biotech had a strong showing at Y Combinator’s latest demo day, with nearly a dozen companies in the space catching my eye. The things a startup can accomplish in this space are astonishing these days, so don’t be surprised if a few of these companies are headline news in the next year. Startups take on big pharma Atom Bioworks has one of the shortest timelines and highest potential impacts; as I wrote in our second set of favorites from demo day, the company seems to be fairly clo...
Tags: Startups, TC, Y Combinator, Tech, Google Docs, Biotech, Nih, Swiss Army, Jennifer Doudna, Yale Harvard, SBIR, Moderna, SageMaker, Nuntius Therapeutics, Atom Bioworks, Nuntius


Ghana’s Redbird raises $1.5M seed to expand access to rapid medical testing in sub-Saharan Africa

For patients and healthcare professionals to properly track and manage illnesses especially chronic ones, healthcare needs to be decentralized . It also needs to be more convenient, with a patient’s health information able to follow them wherever they go . Redbird, a Ghanaian healthtech startup that allows easy access to convenient testing and ensures that doctors and patients can view the details of those test results at any time, announced today that it has raised a $1.5 million s...
Tags: Startups, TC, Enterprise, Boston, Funding, Africa, US, Tech, Diabetes, Healthcare, Biotech, Ghana, Cto, Accra, Kumasi, Saharan Africa


Serimmune launches new immune response mapping service for COVID-19

Immune intelligence startup Serimmune hopes to better understand the relationship between antibody epitopes (the parts of antigen molecules that bind to antibodies) and the SARS-CoV-2 virus. The company’s proprietary technology, originally developed at UC Santa Barbara, provides a new and specific way of mapping the entire array of an individual’s antibodies through a small blood sample. They do this through the use of a bacterial peptide display — a sort of screening mechanism that can isolate ...
Tags: Health, Startups, Science, Medicine, Tech, Disease, Biotech, Immunology, Mapping Technology, Nasser, UC Santa Barbara, UC San Diego, COVID, Serimmune, Noah Nasser


Ghana’s mPharma partners with Ethiopian conglomerate to enter its eighth market

mPharma, a Ghanaian health tech startup that manages prescription drug inventory for pharmacies and their suppliers, today announced its expansion to Ethiopia . The company was founded by Daniel Shoukimas , Gregory Rockson  and James Finucane in 2013 . It specializes in vendor-managed inventory, retail pharmacy operations and market intelligence serving hospitals, pharmacies and patients . In Africa, the pharmaceutical market faces challenges such as sprawling supply chains, ...
Tags: Health, Startups, TC, Nigeria, Africa, Tech, Healthcare, Pizza Hut, Ethiopia, Kenya, Zambia, Novartis, Biotech, Ghana, Cvs, Rwanda


Could Valo Health become one of Flagship Pioneering’s biggest companies yet?

The investment firm Flagship Pioneering has incubated a lot of life sciences companies since it was founded in 2000. In fact, while a general partner with Flagship Pioneering over the last 15 years, David Berry has started more than 30 companies, five of which trade publicly right now: Seres Therapeutics, Sensen Bio, Evelo Biosciences, T2 Biosystems, and Axcella Health. Berry is often a company’s first CEO, then transitions out of the company within 18 months. But he has no plans to leave his po...
Tags: Startups, TC, Medicine, Boston, Tech, Venture Capital, Machine Learning, Biotech, Berry, Opal, David Berry, Drug Discovery, Moderna, Flagship Pioneering, Valo, Recent Funding